Review
doi: 10.1080/10428190500102688.
Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome
Affiliations
- PMID: 16019564
- DOI: 10.1080/10428190500102688
Item in Clipboard
Review
Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome
Leuk Lymphoma.
2005 Jul.
Abstract
Werner's syndrome is an autosomal recessive disorder resulting in premature aging. Most patients die in their fifth decade from malignancies or heart disease. The gene for Werner's syndrome (WRN) encodes a recQ helicase. Cells from patients with Werner's syndrome have increased sensitivity to DNA-damaging drugs in vitro. Here we present a patient with Werner's syndrome who developed severe chemotherapy-induced toxicity during treatment for acute myelogenous leukemia. We propose that lack of WRN resulted in increased sensitivity of the patient's cells to the toxicity of chemotherapy.
Similar articles
-
LMNA mutations in atypical Werner's syndrome.Lancet. 2003 Aug 9;362(9382):440-5. doi: 10.1016/S0140-6736(03)14069-X. Lancet. 2003. PMID: 12927431
-
Werner's syndrome lymphoblastoid cells are hypersensitive to topoisomerase II inhibitors in the G2 phase of the cell cycle.Mutat Res. 2000 Mar 20;459(2):123-33. doi: 10.1016/s0921-8777(99)00065-8. Mutat Res. 2000. PMID: 10725663
-
Covalent modification of the Werner's syndrome gene product with the ubiquitin-related protein, SUMO-1.J Biol Chem. 2000 Jul 14;275(28):20963-6. doi: 10.1074/jbc.C000273200. J Biol Chem. 2000. PMID: 10806190
-
The Werner's Syndrome RecQ helicase/exonuclease at the nexus of cancer and aging.Hawaii Med J. 2011 Mar;70(3):52-5. Hawaii Med J. 2011. PMID: 21365542 Free PMC article. Review.
-
Telomere ResQue and preservation--roles for the Werner syndrome protein and other RecQ helicases.Mech Ageing Dev. 2008 Jan-Feb;129(1-2):79-90. doi: 10.1016/j.mad.2007.10.007. Epub 2007 Oct 30. Mech Ageing Dev. 2008. PMID: 18054793 Review.
Cited by
-
Successful Cord Blood Transplantation in a Werner Syndrome Patient with High-risk Myelodysplastic Syndrome.Intern Med. 2019 Jan 1;58(1):109-113. doi: 10.2169/internalmedicine.0317-17. Epub 2018 Aug 24. Intern Med. 2019. PMID: 30146558 Free PMC article.
-
Exacerbated Renal and Hematologic Toxicities to Ifosfamide and Doxorubicin-Based Chemotherapy in a Patient with Retroperitoneal Liposarcoma Harboring a Germline Mutation in the WRN Gene.Case Rep Oncol. 2022 Mar 4;15(1):170-175. doi: 10.1159/000521624. eCollection 2022 Jan-Apr. Case Rep Oncol. 2022. PMID: 35431856 Free PMC article.
-
Case Report: A novel WRN mutation in Werner syndrome patient with diabetic foot disease and myelodysplastic syndrome.Front Endocrinol (Lausanne). 2022 Jul 15;13:918979. doi: 10.3389/fendo.2022.918979. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35909544 Free PMC article.
-
Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.Front Oncol. 2019 May 22;9:420. doi: 10.3389/fonc.2019.00420. eCollection 2019. Front Oncol. 2019. PMID: 31192125 Free PMC article.
-
The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds.Cancer Chemother Pharmacol. 2009 Apr;63(5):881-7. doi: 10.1007/s00280-008-0793-8. Epub 2008 Aug 2. Cancer Chemother Pharmacol. 2009. PMID: 18677484 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
